Cargando…

Anti-VEGF therapies in the treatment of choroidal neovascularisation secondary to non-age-related macular degeneration: a systematic review

OBJECTIVES: The aim of this study is to systematically review the evidence for anti-vascular endothelial growth factor (VEGF) therapy in choroidal neovascularisation secondary to conditions other than age-related macular degeneration. DATA SOURCES: MEDLINE, MEDLINE in-process, EMBASE and CENTRAL dat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stuart, Arabella, Ford, John A, Duckworth, Susan, Jones, Colin, Pereira, Augustine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2015
Materias:	Ophthalmology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420986/ https://www.ncbi.nlm.nih.gov/pubmed/25941188 http://dx.doi.org/10.1136/bmjopen-2015-007746

Ejemplares similares

Fractal analysis of polypoidal choroidal neovascularisation in age-related macular degeneration
por: Serra, Rita, et al.
Publicado: (2021)

Comparison of antivascular endothelial growth factor treatment for myopia choroidal neovascularisation: a systematic review and meta-analysis of randomised controlled trials
por: Dong, Liming, et al.
Publicado: (2023)

Alpinumisoflavone ameliorates choroidal neovascularisation and fibrosis in age-related macular degeneration in in vitro and in vivo models
por: Yu, Eunhye, et al.
Publicado: (2022)

Macular vortex vein with choroidal neovascularisation in pathologic myopia
por: Schouten, Ike M, et al.
Publicado: (2019)

Effect of total anti-VEGF treatment exposure on patterns of choroidal neovascularisation assessed by optical coherence tomography angiography in age-related macular degeneration: a retrospective case series
por: Faes, Livia, et al.
Publicado: (2019)

Reduction in choroidal thickness of macular area in polypoidal choroidal vasculopathy patients after intravitreal ranibizumab therapy
por: Nishide, Tadayuki, et al.
Publicado: (2013)

Age-Related Macular Degeneration: Epidemiology, Pathophysiology, Diagnosis, and Treatment
por: Vyawahare, Hrishikesh, et al.
Publicado: (2022)

Intravitreal Bevacizumab for Choroidal Neovascular Membrane in Macular Telangiectasia Type 2
por: Gonzalez Martinez, Orlando G, et al.
Publicado: (2023)

Characterisation of macular neovascularisation subtypes in age-related macular degeneration to optimise treatment outcomes
por: Mathis, Thibaud, et al.
Publicado: (2022)

An Analysis of the Usage of Retinal Imaging Technology in the Detection of Age-Related Macular Degeneration
por: Riazi Esfahani, Parsa, et al.
Publicado: (2023)

Visual Outcome after Intravitreal Anti-VEGF Therapy for Macular Neovascularisation Secondary to Sorsby’s Fundus Dystrophy: A Systematic Review
por: Baston, Arthur, et al.
Publicado: (2021)

Subretinal Neovascular Membrane in Wet Age-Related Macular Degeneration Managed With Intravitreal Ranibizumab
por: Sharma, Tanishq S, et al.
Publicado: (2021)

Dietary intervention in patients with age-related macular degeneration: protocol for a randomised controlled trial
por: Tang, Diana, et al.
Publicado: (2019)

A Study of Correlates of Age-Related Macular Degeneration in Patients Attending a Tertiary Hospital
por: Mehta, Kervi, et al.
Publicado: (2022)

Age-Related Macular Degeneration: An Exponentially Emerging Imminent Threat of Visual Impairment and Irreversible Blindness
por: Chaudhuri, Madhurima, et al.
Publicado: (2023)

Intravitreal Anti-vascular Endothelial Growth Factor (Anti-VEGF) Therapy for Valsalva Related Sub-internal Limiting Membrane (Sub-ILM) Macular Haemorrhage: A Case Report
por: Nur-Najwa, Suhaifi, et al.
Publicado: (2023)

Drug treatment of macular oedema secondary to central retinal vein occlusion: a network meta-analysis
por: Ford, John A, et al.
Publicado: (2014)

Is IL-10 a Good Target to Inhibit Choroidal Neovascularisation in Age-Related Macular Disease?
por: Lightman, Sue, et al.
Publicado: (2006)

Co-existence of Age-Related Macular Degeneration and Diabetic Retinopathy in a Tertiary Referral Center in Greece
por: Bourouki, Evgenia, et al.
Publicado: (2022)

Patient perspectives and barriers in the treatment of neovascular age-related macular degeneration in Denmark: a qualitative study
por: Thinggaard, Benjamin Sommer, et al.
Publicado: (2023)

Anti-vascular Endothelial Growth Factor Outpatient Treatment Patterns in Patients with Exudative Age-related Macular Degeneration from a Japanese Hospital Claims Database
por: Iida, Tomohiro, et al.
Publicado: (2014)

Healthcare experiences of patients with age-related macular degeneration: have things improved? Cross-sectional survey responses of Macular Society members in 2013 compared with 1999
por: Boxell, Emily M, et al.
Publicado: (2017)

Deep Learning Classification of Drusen, Choroidal Neovascularization, and Diabetic Macular Edema in Optical Coherence Tomography (OCT) Images
por: Riazi Esfahani, Parsa, et al.
Publicado: (2023)

Pain related to intravitreal injections for age-related macular degeneration: a qualitative study of the perspectives of patients and practitioners
por: Yiallouridou, Christina, et al.
Publicado: (2023)

Quantitative assessment of retinal fluid in neovascular age-related macular degeneration under anti-VEGF therapy
por: Reiter, Gregor S., et al.
Publicado: (2022)

Patient experience of treatment decision making for wet age-related macular degeneration disease: a qualitative study in China
por: Bian, Wei, et al.
Publicado: (2019)

Clinical Wide-Field Retinal Image Deep Learning Classification of Exudative and Non-Exudative Age-Related Macular Degeneration
por: Tak, Nathaniel, et al.
Publicado: (2021)

Cross-sectional study evaluating burden and depressive symptoms in family carers of persons with age-related macular degeneration in Australia
por: Jin, Ivan, et al.
Publicado: (2021)

Eligibility for faricimab in a real-world neovascular age-related macular degeneration population: a cross-sectional study
por: Jern, Iréne, et al.
Publicado: (2022)

Faricimab Effectively Resolves Intraretinal Fluid and Preserves Vision in Refractory, Recalcitrant, and Nonresponsive Neovascular Age-Related Macular Degeneration
por: Cheng, Anny M, et al.
Publicado: (2023)

Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial
por: Singerman, L J, et al.
Publicado: (2008)

Choroidal Neovascularization and Toxic Optic Neuropathy Secondary to Tobacco Use: A Case Report
por: Islam, Yasmin, et al.
Publicado: (2020)

Neuropilin 1 Involvement in Choroidal and Retinal Neovascularisation
por: Fernández-Robredo, Patricia, et al.
Publicado: (2017)

Matrix Metalloproteinase 10 Contributes to Choroidal Neovascularisation
por: González-Zamora, Jorge, et al.
Publicado: (2022)

Response of Pediatric Choroidal Neovascularization to Anti-Vascular Endothelial Growth Factor
por: Ruparelia, Sunil, et al.
Publicado: (2021)

How does age-related macular degeneration affect real-world visual ability and quality of life? A systematic review
por: Taylor, Deanna J, et al.
Publicado: (2016)

Accuracy of a Self-monitoring Test for Identification and Monitoring of Age-related Macular Degeneration: A Diagnostic Case-control Study
por: Schmid, Martin K., et al.
Publicado: (2018)

Association of age-related macular degeneration on fracture risks among osteoporosis population: a nationwide population-based cohort study
por: Sun, Chi Chin, et al.
Publicado: (2020)

Combined Administration of Preoperative Intravitreal and Intraoperative Subretinal Recombinant Tissue Plasminogen Activator in Acute Hemorrhagic Age-related Macular Degeneration
por: Helaiwa, Khaled, et al.
Publicado: (2020)

Association between metformin use and the risk of age-related macular degeneration in patients with type 2 diabetes: a retrospective study
por: Jiang, Jingjing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b9qju213pkfbpcsauieh5nu1mh